Jorge Sabbaga

4.0k total citations · 1 hit paper
63 papers, 2.7k citations indexed

About

Jorge Sabbaga is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Jorge Sabbaga has authored 63 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 22 papers in Surgery and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Jorge Sabbaga's work include Colorectal Cancer Treatments and Studies (20 papers), Colorectal and Anal Carcinomas (15 papers) and Colorectal Cancer Surgical Treatments (13 papers). Jorge Sabbaga is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Colorectal and Anal Carcinomas (15 papers) and Colorectal Cancer Surgical Treatments (13 papers). Jorge Sabbaga collaborates with scholars based in Brazil, United States and Belgium. Jorge Sabbaga's co-authors include Rodrigo Oliva Perez, Angelita Habr‐Gama, Joaquim Gama‐Rodrigues, Wladimir Nadalin, Fábio Guilherme Campos, Desidério Roberto Kiss, Ulysses Ribeiro, Afonso Henrique Silva e Sousa, Guilherme Pagin São Julião and Paulo M. Hoff and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jorge Sabbaga

59 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy

2004 1.2k citations Angelita Habr‐Gama, Rodrigo Oliva Perez et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorge Sabbaga Brazil	18	2.1k	1.5k	523	470	246	63	2.7k
D. Fennelly Ireland	25	1.8k 0.8×	878 0.6×	564 1.1×	157 0.3×	377 1.5×	85	2.6k
JA Ledermann United Kingdom	24	904 0.4×	764 0.5×	439 0.8×	311 0.7×	113 0.5×	69	2.0k
Heung-Moon Chang South Korea	25	1.4k 0.7×	673 0.5×	908 1.7×	237 0.5×	284 1.2×	79	2.1k
Joaquina Baranda United States	22	1.9k 0.9×	868 0.6×	891 1.7×	136 0.3×	286 1.2×	105	2.7k
Cornelius J. McGinn United States	27	1.6k 0.7×	711 0.5×	1.5k 2.9×	550 1.2×	453 1.8×	38	3.3k
Thomas Powles United Kingdom	24	2.4k 1.1×	1.9k 1.3×	1.1k 2.1×	174 0.4×	430 1.7×	105	3.7k
Bradley A. McGregor United States	27	1.8k 0.8×	1.2k 0.8×	1.4k 2.7×	193 0.4×	573 2.3×	176	3.2k
D. De Raucourt France	22	2.2k 1.0×	1.9k 1.3×	1.9k 3.6×	273 0.6×	306 1.2×	55	4.4k
Flavio G. Rocha United States	27	2.1k 1.0×	1.3k 0.9×	947 1.8×	116 0.2×	385 1.6×	138	2.9k
Pei-Rong Ding China	20	1.2k 0.6×	532 0.4×	271 0.5×	91 0.2×	271 1.1×	45	1.6k

Countries citing papers authored by Jorge Sabbaga

Since Specialization

Citations

This map shows the geographic impact of Jorge Sabbaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Sabbaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Sabbaga more than expected).

Fields of papers citing papers by Jorge Sabbaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Sabbaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Sabbaga. The network helps show where Jorge Sabbaga may publish in the future.

Co-authorship network of co-authors of Jorge Sabbaga

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Sabbaga. A scholar is included among the top collaborators of Jorge Sabbaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Sabbaga. Jorge Sabbaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sabbaga, Jorge, et al.. (2024). Prognostic role of albumin-bilirubin (ALBI) score and Child-Pugh classification in patients with advanced hepatocellular carcinoma under systemic treatment. ecancermedicalscience. 18. 1748–1748. 3 indexed citations

Neto, Felippe Lazar, Evandro Sobroza de Mello, Jorge Sabbaga, et al.. (2024). Survival impact of KRAS mutation in metastatic colorectal cancer (mCCR) under first-line treatment.. Journal of Clinical Oncology. 42(16_suppl). 3547–3547.

Bonadio, Renata Colombo, et al.. (2021). Epidemiology and Outcomes of Patients With Brain Metastases From Colorectal Cancer—Who Are These Patients?. Clinical Colorectal Cancer. 20(3). e195–e200. 8 indexed citations

Marta, Guilherme Nader, Leonardo Gomes da Fonseca, Maria Ignez Braghiroli, et al.. (2021). Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma. Clinics. 76. e2498–e2498. 9 indexed citations

Moniz, Camila Motta Venchiarutti, Rachel P. Riechelmann, Giovanni M. Bariani, et al.. (2021). A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes. Journal of Cancer. 12(23). 7018–7025. 3 indexed citations

Knebel, Franciele Hinterholz, Louise J. Barber, Alice Newey, et al.. (2020). Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy. Cancers. 12(12). 3736–3736. 4 indexed citations

Caparica, Rafael, Alain Hendlisz, Evandro de Azambuja, et al.. (2020). Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy. BMJ Supportive & Palliative Care. 14(e2). e1882–e1888. 3 indexed citations

Moniz, Camila Motta Venchiarutti, et al.. (2020). Real-world Data for High-risk Stage II Colorectal Cancer – The Role of Tumor Side in the Adjuvant Setting. Clinical Colorectal Cancer. 20(2). e100–e108. 2 indexed citations

Knebel, Franciele Hinterholz, Fabiana Bettoni, Leonardo Gomes da Fonseca, et al.. (2019). Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer. Frontiers in Oncology. 9. 170–170. 13 indexed citations

10.

Girardi, Daniel M., et al.. (2018). Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis. BMC Cancer. 18(1). 378–378. 4 indexed citations

11.

Ramos, Ricardo, et al.. (2016). Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community. Clinical Colorectal Cancer. 16(1). 65–72. 4 indexed citations

12.

Miranda, Vanessa Costa, Maria Ignez Braghiroli, Luiza Dib Batista Bugiato Faria, et al.. (2016). Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 15(4). 321–328.e1. 60 indexed citations

13.

Fonseca, Leonardo Gomes da, et al.. (2015). Safety and efficacy of sorafenib in patients with Child-Pugh B advanced hepatocellular carcinoma. Molecular and Clinical Oncology. 3(4). 793–796. 25 indexed citations

14.

Sabbaga, Jorge, et al.. (2014). The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients With an ECOG Performance Status of 3 and 4. Clinical Colorectal Cancer. 14(1). 52–57. 31 indexed citations

15.

Fonseca, Leonardo Gomes da, et al.. (2014). Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Medical Oncology. 31(11). 264–264. 40 indexed citations

16.

Habr‐Gama, Angelita, Jorge Sabbaga, Joaquim Gama‐Rodrigues, et al.. (2013). Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer. Diseases of the Colon & Rectum. 56(10). 1109–1117. 302 indexed citations

17.

Foster, Mary H., et al.. (1993). Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse.. The Journal of Immunology. 151(2). 814–824. 44 indexed citations

18.

Santos, Cecília L. S., Jorge Sabbaga, & Helena Brentani. (1991). Differences in human laminin B2 sequences. DNA sequence. 1(4). 275–277.

19.

Mackworth-Young, C G, Ewa Cairns, Jorge Sabbaga, et al.. (1990). Comparative study of idiotypes on monoclonal antibodies derived from patients with lupus and leprosy and from normal individuals. Journal of Autoimmunity. 3(4). 415–429. 7 indexed citations

20.

Sabbaga, Jorge, et al.. (1990). Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. Journal of Autoimmunity. 3(2). 215–235. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact